FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved a supplemental application for carvedilol (Advagen Pharma Ltd) under an ANDA, authorizing a supplemental approval for this generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Left Ventricular Dysfunction Following Myocardial Infarction

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)